Searched for
ANKLESHWAR FACILITY
Community boiler pioneer Steamhouse India files UDRHP with Sebi for Rs 425 cr IPOSteamhouse India Ltd has filed its Updated Draft Red Herring Prospectus I (UDRHP I) with Securities and Exchange Board of India (SEBI) for ...- Zydus Lifesciences shares in focus after Ahmedabad oncology injectable plant gets two FDA observationsZydus Lifesciences shares: The follow-up audit, conducted under Good Manufacturing Practices (GMP), took place from June 9 to June 18, 2025...
- Covaxin supply set to rise as new plant goes on streamThe Ankleshwar plant, constructed in 2020, has a manufacturing capacity of more than 10 million doses per month, and supplies will be avail...
- Health minister Mansukh Mandaviya releases first batch of Covaxin from Bharat Biotech's Gujarat plant"Vaccination is the most important thing to strengthen the country's fight against coronavirus. Released the first commercial batch of #COV...
- Bharat Biotech gets nod to make Covaxin at Gujarat facility“The drug regulator has given test licence and manufacturing licence for the facility, which means that the facility is now ready to start ...
- Govt approves Bharat Biotech's Ankleshwar plant to produce Covaxin: Mandaviya"Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat," Mandaviya tweet...
- Covaxin receives GMP certificate from Hungary: Bharat BiotechBharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.
- Add Sanofi India, target price Rs 7,680: CentrumRevenue growth excluding export for the domestic business continues to be at mid-high single digits.
- Zydus Cadila gets EIR from USFDA for Ankleshwar facilityThe company's active pharmaceutical ingredient (API) manufacturing facility located at Ankleshwar (unit 1), Gujarat has received an Establi...
- Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
- Glenmark's Ankleshwar plant gets EIR report from USFDA"The EIR is issued by the FDA only if it finds the facility to be deemed acceptable," the company said in a BSE filing.
- Alkem gets 3 FDA observations post Ankleshwar unit inspectionThe company shall put together a detailed response with adequate corrective and preventive measures to address the USFDA observations.
- Lyka Labs sells Tarapur manufacturing unit for Rs 38.6 croreDrug firm Lyka Labs has sold its formulation manufacturing unit at Tarapur for Rs 38.61 crore.
- Sanofi inks pact with Suzlon for captive power plantDrug firm Sanofi India today said it has inked a pact with Suzlon Energy for a 2.1 megawatt windmill installation.
- Sanofi India to use renewable energy for its Ankleshwar manufacturing siteSanofi India announced that it has signed an agreement with India's largest wind turbine manufacturer, SEL, for a 2.1 MW offsite windmill i...
- Sanofi's Ankleshwar unit to use renewable energySanofi India Limited is exploring the use of renewable energy sources for its manufacturing operations at Ankleshwar site. The company said...
- US drug regulator issues warning letter to RPG Life SciencesUSFDA has issued a warning letter to RPG Life Sciences for violation of current good manufacturing practice (CGMP) norms at its two plants ...
- Huntsman acquires Laffans PetrochemicalsHuntsman Corporation said it has taken over Gujarat-based Laffans Petrochemicals and has also taken ownership of company's ethylene oxide d...
- MP High Court order faces criticism in AnkleshwarVillagers in Jitali and surrounding villages near Ankleshwar have decided to launch an agitation opposing the MP High Court order allowing ...
- Rallis opens Gujarat plant to build polymer for aerospace industryGujarat will now house the world’s only facility to produce poly ether ketone ketone (PEKK), a high-end application polymer used in the aer...
Load More
